tiprankstipranks
Trending News
More News >
Shin Nippon Biomedical Laboratories, Ltd. (JP:2395)
:2395
Japanese Market

Shin Nippon Biomedical Laboratories, Ltd. (2395) Revenue

Compare
2 Followers

Shin Nippon Biomedical Laboratories, Ltd. Revenue

Shin Nippon Biomedical Laboratories, Ltd. had a revenue of 5.55B in the quarter ending Jun 30, 2024, with -34.45%. This bring the company's revenue in the last twelve months to 26.20B, Increased -0.97%. In the fiscal year ending Mar 31, 2024, Shin Nippon Biomedical Laboratories, Ltd. had annual revenue of 26.45B with 5.42% growth.
Revenue (ttm)
26.20B
Revenue Growth
14.97%
P/S Ratio
2.04
Revenue/Employee
¥18,154,062
Employees
1,457
Market Cap
¥53.91B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Mar 31, 2024
26.45B1.36B+5.42%
Mar 31, 2023
25.09B7.34B+41.37%
Mar 31, 2022
17.75B2.64B+17.46%
Mar 31, 2021
15.11B549.46M+3.77%
Mar 31, 2020
14.56B-1.10B-7.01%
Mar 31, 2019
15.66B
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis